Based on in-depth interviews with insurance executives operating in the region, a study commissioned by Peak Re revealed a hopeful outlook for risk protection products which mitigate exposure to non-communicable and critical diseases. Reasons behind this outlook include regulatory and public policy encouragement as well as a generally weak condition of savings and investment products. Despite the optimism, morbidity risks were found to be the most critical protection gap in emerging Asia given the rapid rise of cancer, diabetes and cardiovascular diseases.